All the news Showing 10 of 284 articles from: Access to medicines & diagnosticsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources CHAI releases first-ever Hepatitis C Market Report Clinton Health Access Initiative / 28 May 2020 The Medicines Patent Pool and Mylan sign agreement to scale up access to first generic version of hepatitis C treatment glecaprevir/pibrentasvir Medicines Patent Pool / 24 February 2020 Malaysia: Stage set for access to Hepatitis C treatment Star Online / 13 November 2019 Cost of Hepatitis C Drug Skyrockets 1,422% after Patent Approval Folha de S.Paulo / 24 October 2019 Global hepatitis response gains ground – More action needed to achieve universal health coverage targets World Health Organization / 12 April 2019 Armenia gets license to produce drugs for hepatitis C treatment Public Radio of Armenia / 03 April 2019 Louisiana picks drug company for hepatitis C treatment plan San Francisco Chronicle / 27 March 2019 Interview With Charles Gore, Medicines Patent Pool Executive Director Intellectual Property Watch / 24 March 2019 Countries Use Novel Strategies to Tackle Price of HCV Drugs Medscape / 15 February 2019 Malaysia Still Under Pressure To Make Hepatitis C Medicine More Expensive Intellectual Property Watch / 15 February 2019 ← Prev12345...29Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive